- Home
- NCLH vs VTAK Comparison
NCLH vs VTAK Comparison
Compare NCLH & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCLH
- VTAK
- Stock Information
- Founded
- NCLH 1966
- VTAK 2002
- Country
- NCLH United States
- VTAK United States
- Employees
- NCLH N/A
- VTAK N/A
- Industry
- NCLH Marine Transportation
- VTAK Medical/Dental Instruments
- Sector
- NCLH Consumer Discretionary
- VTAK Health Care
- Exchange
- NCLH Nasdaq
- VTAK Nasdaq
- Market Cap
- NCLH N/A
- VTAK 1.1M
- IPO Year
- NCLH 2013
- VTAK 2018
- Fundamental
- Price
- NCLH $23.40
- VTAK $0.36
- Analyst Decision
- NCLH Buy
- VTAK
- Analyst Count
- NCLH 15
- VTAK 0
- Target Price
- NCLH $23.30
- VTAK N/A
- AVG Volume (30 Days)
- NCLH 14.7M
- VTAK 245.0K
- Earning Date
- NCLH 10-30-2024
- VTAK 08-14-2024
- Dividend Yield
- NCLH N/A
- VTAK N/A
- EPS Growth
- NCLH N/A
- VTAK N/A
- EPS
- NCLH 0.95
- VTAK N/A
- Revenue
- NCLH $9,086,200,000.00
- VTAK $436,000.00
- Revenue This Year
- NCLH $12.23
- VTAK $637.10
- Revenue Next Year
- NCLH $7.68
- VTAK $177.13
- P/E Ratio
- NCLH $24.61
- VTAK N/A
- Revenue Growth
- NCLH 26.87
- VTAK 140.88
- 52 Week Low
- NCLH $12.71
- VTAK $0.31
- 52 Week High
- NCLH $23.82
- VTAK $8.40
- Technical
- Relative Strength Index (RSI)
- NCLH 74.71
- VTAK 29.12
- Support Level
- NCLH $19.92
- VTAK $0.35
- Resistance Level
- NCLH $20.63
- VTAK $0.54
- Average True Range (ATR)
- NCLH 0.81
- VTAK 0.05
- MACD
- NCLH 0.25
- VTAK 0.05
- Stochastic Oscillator
- NCLH 99.34
- VTAK 19.65
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.